Holding(s) in Company (1808641)
04 Gennaio 2024 - 6:30PM
UK Regulatory
Arix Bioscience PLC (ARIX)
Holding(s) in Company
04-Jan-2024 / 17:30 GMT/BST
=----------------------------------------------------------------------------------------------------------------------
TR-1: Standard form for notification of major holdings
NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)
i
1a. Identity of the issuer or the underlying issuer of existing shares to ARIX Bioscience PLC
which voting rights are attachedii:
1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)
Non-UK issuer
2. Reason for the notification (please mark the appropriate box or boxes with an "X")
An acquisition or disposal of voting rights
An acquisition or disposal of financial instruments X
An event changing the breakdown of voting rights
Other (please specify)iii:
3. Details of person subject to the notification obligationiv
Name Weiss Asset Management LP
City and country of registered office (if applicable) Wilmington, Delaware, USA
4. Full name of shareholder(s) (if different from 3.)v
Name Brookdale International Partners, L.P.,
Brookdale Global Opportunity Fund
Brookdale International Partners, L.P.:
Albany, NY, USA
City and country of registered office (if applicable)
Brookdale Global Opportunity Fund: Grand
Cayman, Cayman Islands
5. Date on which the threshold was crossed or reachedvi: January-2-2024
6. Date on which issuer notified (DD/MM/YYYY): January-4-2024
7. Total positions of person(s) subject to the notification obligation
% of voting rights
% of voting rights through financial Total of both Total number of
attached to shares (total instruments in % (8.A + voting rights of
of 8. A) (total of 8.B 1 + 8.B 8.B) issuervii
2)
Resulting situation on the date on
which threshold was crossed or 0.00 5.19 5.19 129,389,508
reached
Position of previous notification
(if
N/A N/A N/A
applicable)
8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii
A: Voting rights attached to shares
Number of voting rightsix % of voting rights
Class/type of
shares Direct Indirect Direct Indirect
ISIN code (if (Art 9 of Directive (Art 10 of Directive (Art 9 of Directive 2004/109/ (Art 10 of Directive
possible) 2004/109/EC) (DTR5.1) 2004/109/EC) (DTR5.2.1) EC) (DTR5.1) 2004/109/EC)
(DTR5.2.1)
SUBTOTAL 8. A
B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))
Type of Number of voting rights that may be
financial Expiration Exercise/ acquired if the instrument is % of voting rights
instrument datex Conversion Periodxi
exercised/converted.
SUBTOTAL 8. B 1
B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1
(b))
Type of Expiration Exercise/ Physical or cash
financial datex Conversion Number of voting rights % of voting rights
instrument Period xi settlementxii
CFD N/A N/A Cash Settlement 6,725,000 5.19
SUBTOTAL 8.B.2 6,725,000 5.19
9. Information in relation to the person subject to the notification obligation (please mark the
applicable box with an "X")
Person subject to the notification obligation is not controlled by any natural person or legal entity
and does not control any other undertaking(s) holding directly or indirectly an interest in the
(underlying) issuerxiii
Full chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held starting with the ultimate controlling natural person or x
legal entityxiv (please add additional rows as necessary)
% of voting rights if it % of voting rights through financial Total of both if it equals or
Namexv equals or is higher than the instruments if it equals or is higher than is higher than the notifiable
notifiable threshold the notifiable threshold threshold
Weiss Asset
Management LP
Brookdale
International 0.00 2.90 2.90
Partners, L.P.
Weiss Asset
Management LP
Brookdale
Global 0.00 2.29 2.29
Opportunity
Fund
10. In case of proxy voting, please identify:
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be
held
11. Additional informationxvi
Weiss Asset Management LP is the Investment Manager to Brookdale Global Opportunity Fund and Brookdale International
Partners, L.P.
Place of completion Boston, USA
Date of completion January-4-2024
-----------------------------------------------------------------------------------------------------------------------
Dissemination of a Regulatory Announcement, transmitted by EQS
Group. The issuer is solely responsible for the content of this
announcement.
-----------------------------------------------------------------------------------------------------------------------
ISIN: GB00BD045071
Category Code: HOL
TIDM: ARIX
LEI Code: 213800OVT3AHQCXNIX43
OAM Categories: 2.3. Major shareholding notifications
Sequence No.: 295596
EQS News ID: 1808641
End of Announcement EQS News Service
=------------------------------------------------------------------------------------
Image link:
https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1808641&application_name=news
(END) Dow Jones Newswires
January 04, 2024 12:30 ET (17:30 GMT)
Grafico Azioni Arix Bioscience (LSE:ARIX)
Storico
Da Apr 2024 a Mag 2024
Grafico Azioni Arix Bioscience (LSE:ARIX)
Storico
Da Mag 2023 a Mag 2024
